TARS Tarsus Pharmaceuticals, Inc.

NASDAQ
$73.01

Tarsus Pharmaceuticals, Inc. (TARS) Earnings News

Earnings press releases, previews and reviews for Tarsus Pharmaceuticals, Inc. (TARS), newest first. Our most recent is review: Tarsus Beats as XDEMVY Guidance Rises Again, but a $632 Million Pipeline Bet Reshapes the Balance Sheet.